IP Verse

Ter Meer Steinmeister & Partner patent opposition analysis

The comprehensive analysis of Ter Meer Steinmeister & Partner opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Latest patent oppositions filed by Ter Meer Steinmeister & Partner

Stay updated with the latest patent oppositions filed by Ter Meer Steinmeister & Partner

Patent NumberTitleApplicantOpposition DateOpposition Company
EP3914247
Use Of Migalostat In Reducing The Risk Of Cerebrovascular Event In Patients With Fabry DiseaseAMICUS THERAPEUTICSAug 13, 2025SANDOZ
EP3689365
Use Of Long-Acting Glp-1 PeptidesNOVO NORDISKAug 7, 2025GENERICS UK
EP4125903
Methods For Dose Initiation Of Aripiprazole TreatmentsOTSUKA PHARMACEUTICALJul 8, 2025RUMI
EP3897582
Process Of Spray Drying Of Glp-1 PeptideNOVO NORDISKJun 11, 2025GENERICS UK
EP3984365
Aqueous Disinfectant Composition Containing Peracetic AcidSUMOJun 11, 2025BODE CHEMIE
EP4065119
Methods Of Treating Pulmonary Arterial HypertensionACTELION PHARMACEUTICALSJun 4, 2025SANDOZ
EP3506931
Methods For Preventing Or Treating Allergy By Administering An Il-4R AntagonistREGENERON PHARMACEUTICALSApr 29, 2025LUIGI
EP4054620
Glp-1 Receptor Agonists In DementiaNOVO NORDISKFeb 27, 2025GENERICS UK
EP3889181
Methods For Treating Atopic Dermatitis By Administering An Il-4R AntagonistSANOFI BIOTECHNOLOGYJan 24, 2025LUIGI
EP2662094
Cylodextrin Complexation Methods For Formulating Peptide Proteasome InhibitorsONYX THERAPEUTICSJan 17, 2025RUMI

Top clients of Ter Meer Steinmeister & Partner

Top companies who are the clients of Ter Meer Steinmeister & Partner

CompanyTotal
GENERICS UK67
AECHTER33
SANDOZ28
TER MEER STEINMEISTER & PARTNER PATENTANWALTE MBB18
LUIGI16
HEXAL14
PAUL HARTMANN13
ACCORD HEALTHCARE12
HOLLATZ6
PRECITEC5